Alprazolam-induced dyscontrol in borderline personality disorder

Abstract
The authors report a significant increase in dyscontrol in patients with borderline personality disorder who were taking alprazolam during a double-blind, placebo-controlled crossover study. They suggest that caution be used in prescribing alprazolam to patients with similar histories.

This publication has 8 references indexed in Scilit: